Oxford BioTherapeutics Company
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
Technology:
AgeTech Companies
Industry:
Deep diagnostics
Headquarters:
Oxton, York, United Kingdom
Founded Date:
2004-01-01
Employees Number:
11-50
Total Funding:
$33,217,286.00
Estimated Revenue:
$1M to $10M
Last Funding Type:
Undisclosed
Register and Claim Ownership